FDA Approves Janssen Biotech Inc.'s Simponi to Treat Ulcerative Colitis
5/16/2013 7:39:42 AM
More...
|
Araxes Pharma Enters Into Cancer Drug Discovery and Development Agreement With Janssen Biotech Inc.
2/27/2013 9:43:22 AM
More...
|
Abbott Molecular, Inc. Forms Pact With Janssen Biotech Inc. for Leukemia Test
2/21/2013 7:28:03 AM
More...
|
Phenex Pharmaceuticals AG Signs License Agreement With Janssen Biotech Inc. for Up to $135 Million
12/17/2012 8:11:40 AM
More...
|
Genmab A/S (GEN.CO) Reaches Milestone in DuoBody Platform Collaboration With Janssen Biotech Inc.
12/11/2012 9:37:10 AM
More...
|
Janssen Biotech Inc. Submits Applications Requesting Approval of STELARA® in U.S. and Europe for Treatment of Active Psoriatic Arthritis
12/6/2012 9:43:46 AM
More...
|
Janssen Biotech Inc. Release: What Men Should Know About Prostate Cancer -- But Don't
11/9/2012 1:59:57 PM
More...
|
Janssen Biotech Inc. Release: New Data Demonstrate STELARA® (Ustekinumab) is Effective and Improves Quality of Life in Patients With Moderate to Severe Plaque Psoriasis
10/3/2012 10:17:12 AM
More...
|
Johnson & Johnson (JNJ)'s Janssen Biotech Inc. and Astellas Pharma Inc. (YPH.BE) Strike Potential $945 Million Deal for Oral RA Drug
10/2/2012 7:15:36 AM
More...
|
Johnson & Johnson (JNJ)'s Janssen Biotech Inc. Unit Submits BLA for Anti-TNF)-alpha SIMPONI
9/19/2012 6:59:11 AM
More...
|
|